| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-07 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.19 | 9e-08 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.089 | 0.1 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |